Cargando…
Variant biomarker discovery using mass spectrometry-based proteogenomics
Genomic diversity plays critical roles in risk of disease pathogenesis and diagnosis. While genomic variants—including single nucleotide variants, frameshift variants, and mis-splicing isoforms—are commonly detected at the DNA or RNA level, their translated variant protein or polypeptide products ar...
Autores principales: | Reilly, Luke, Seddighi, Sahba, Singleton, Andrew B., Cookson, Mark R., Ward, Michael E., Qi, Yue A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165118/ https://www.ncbi.nlm.nih.gov/pubmed/37168844 http://dx.doi.org/10.3389/fragi.2023.1191993 |
Ejemplares similares
-
The Role of Mass Spectrometry and Proteogenomics in the Advancement of HLA Epitope Prediction
por: Creech, Amanda L., et al.
Publicado: (2018) -
Proteogenomic Analysis of Mycobacterium smegmatis Using High Resolution Mass Spectrometry
por: Potgieter, Matthys G., et al.
Publicado: (2016) -
A fully automated FAIMS-DIA mass spectrometry-based proteomic pipeline
por: Reilly, Luke, et al.
Publicado: (2023) -
Proteogenomic analysis of pathogenic yeast Cryptococcus neoformans using high resolution mass spectrometry
por: Nagarajha Selvan, Lakshmi Dhevi, et al.
Publicado: (2014) -
Proteomics and Mass Spectrometry for Cancer Biomarker Discovery
por: Lu, Ming, et al.
Publicado: (2007)